Pinion Investment Advisors LLC Makes New $787,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Pinion Investment Advisors LLC bought a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm bought 1,590 shares of the medical equipment provider's stock, valued at approximately $787,000.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Vanguard Group Inc. lifted its holdings in Intuitive Surgical by 1.1% during the fourth quarter. Vanguard Group Inc. now owns 32,212,196 shares of the medical equipment provider's stock worth $16,813,478,000 after acquiring an additional 360,591 shares during the period. Geode Capital Management LLC boosted its holdings in shares of Intuitive Surgical by 3.2% in the 4th quarter. Geode Capital Management LLC now owns 7,756,727 shares of the medical equipment provider's stock worth $4,039,200,000 after buying an additional 243,802 shares during the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Intuitive Surgical by 1.8% in the 4th quarter. Fisher Asset Management LLC now owns 4,868,869 shares of the medical equipment provider's stock worth $2,541,356,000 after buying an additional 86,488 shares during the last quarter. Norges Bank bought a new position in Intuitive Surgical during the fourth quarter valued at about $2,401,493,000. Finally, Invesco Ltd. increased its holdings in Intuitive Surgical by 7.7% during the fourth quarter. Invesco Ltd. now owns 4,148,180 shares of the medical equipment provider's stock worth $2,165,184,000 after buying an additional 295,025 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on ISRG. Deutsche Bank Aktiengesellschaft cut shares of Intuitive Surgical from a "hold" rating to a "sell" rating and dropped their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. BTIG Research set a $560.00 price target on shares of Intuitive Surgical and gave the stock a "buy" rating in a report on Monday, April 14th. Barclays dropped their price objective on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a research note on Thursday, April 24th. Citigroup reissued a "buy" rating and issued a $650.00 target price (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Finally, Robert W. Baird lowered their target price on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a research note on Wednesday, April 23rd. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical has an average rating of "Moderate Buy" and an average target price of $588.95.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 215 shares of the firm's stock in a transaction dated Monday, June 2nd. The stock was sold at an average price of $549.06, for a total transaction of $118,047.90. Following the transaction, the senior vice president now directly owns 1,768 shares of the company's stock, valued at approximately $970,738.08. This trade represents a 10.84% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, EVP Gary Loeb sold 1,700 shares of the company's stock in a transaction that occurred on Friday, April 25th. The stock was sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the sale, the executive vice president now directly owns 2,245 shares of the company's stock, valued at approximately $1,152,089.10. This represents a 43.09% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 4,998 shares of company stock worth $2,611,577 in the last ninety days. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Stock Performance

NASDAQ ISRG traded down $2.62 on Wednesday, hitting $509.49. The stock had a trading volume of 1,169,146 shares, compared to its average volume of 1,674,697. The firm has a 50-day moving average of $527.58 and a 200-day moving average of $538.12. Intuitive Surgical, Inc. has a 52-week low of $413.82 and a 52-week high of $616.00. The company has a market capitalization of $182.61 billion, a price-to-earnings ratio of 74.71, a price-to-earnings-growth ratio of 5.51 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The firm had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a net margin of 28.41% and a return on equity of 14.43%. During the same quarter in the prior year, the firm posted $1.50 earnings per share. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.